Russell, A. L., Lefavor, R. C., & Zubair, A. C. (2018). Characterization and cost–benefit analysis of automated bioreactor‐expanded mesenchymal stem cells for clinical applications. Transfusion (Philadelphia, Pa.), 58(10), 2374-2382. https://doi.org/10.1111/trf.14805
Chicago Style (17th ed.) CitationRussell, Athena L., Rebecca C. Lefavor, and Abba C. Zubair. "Characterization and Cost–benefit Analysis of Automated Bioreactor‐expanded Mesenchymal Stem Cells for Clinical Applications." Transfusion (Philadelphia, Pa.) 58, no. 10 (2018): 2374-2382. https://doi.org/10.1111/trf.14805.
MLA (9th ed.) CitationRussell, Athena L., et al. "Characterization and Cost–benefit Analysis of Automated Bioreactor‐expanded Mesenchymal Stem Cells for Clinical Applications." Transfusion (Philadelphia, Pa.), vol. 58, no. 10, 2018, pp. 2374-2382, https://doi.org/10.1111/trf.14805.